https://scholars.lib.ntu.edu.tw/handle/123456789/638373
標題: | A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease | 作者: | Romero-Gómez, Manuel Lawitz, Eric Shankar, R Ravi Chaudhri, Eirum Liu, Jie Lam, Raymond L H Kaufman, Keith D Engel, Samuel S CHUN-JEN LIU et al. |
關鍵字: | efinopegdutide; liver fat content; nonalcoholic fatty liver disease; semaglutide | 公開日期: | 十月-2023 | 卷: | 79 | 期: | 4 | 來源出版物: | Journal of hepatology | 摘要: | This study assessed the effects of the glucagon-like peptide-1 (GLP-1)/glucagon receptor co-agonist efinopegdutide relative to the selective GLP-1 receptor agonist semaglutide on liver fat content (LFC) in patients with non-alcoholic fatty liver disease (NAFLD). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/638373 | ISSN: | 01688278 | DOI: | 10.1016/j.jhep.2023.05.013 |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。